Editorial Board

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

Our editorial board is comprised of clinical and pharmacological experts, organized primarily by disease focus. Most disease types now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].

Editor-in-Chief

PeterYang.jpg
Peter C. Yang, MD
Boston, MA

Social-twitter-icon.png Hem_Onc
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts.

Deputy Editor

Warner Jeremy2 compact.jpg
Jeremy L. Warner, MD, MS, FAMIA, FASCO
Vanderbilt University
Nashville, TN

Social-twitter-icon.png Hemoncwarner
LinkedIn
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.

Associate Editors

Clinical Pharmacology
Donnarivera2.jpg
Donna Rivera, PharmD, MSc
National Cancer Institute
Rockville, MD
Dr. Rivera is a Scientific Project Officer in the Surveillance Informatics Branch of the Surveillance Research Program in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI).
Evidence-based Oncology
Bishalgyawali.jpg
Bishal Gyawali, MD, PhD
Queen’s University
Kingston, Canada

Social-twitter-icon.png oncology_bg
Dr. Gyawali is an assistant professor in the Department of Public Health Sciences at Queen’s University, Kingston, Canada. He is an advocate of "cancer groundshot", a term he coined to imply that investment should be made on proven high-value interventions in cancer care that are easy to implement globally and are affordable.

Section Editors

Breast Oncology
Fernandes Hermina WEB160x200.jpg
Hermina Fernandes, MD, FACP
Bismarck, ND
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the Edith Sanford Breast Center at Sanford Health. She is a clinical associate professor at the University of North Dakota.
Dermatologic Oncology
Bethbuchbinder.jpg
Elizabeth Buchbinder, MD
Boston, MA

LinkedIn
Dr. Buchbinder is board certified in Medical Oncology; she practices at the Dana-Farber Cancer Institute. She is an instructor at Harvard Medical School.
Endocrine Oncology
Unfilled If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Gastrointestinal Oncology
Nkv.jpg
Neeta K. Venepalli, MD, MBA
Chicago, IL
Dr. Venepalli is board certified in Medical Oncology; she practices at UI Health. She is an associate professor at the University of Illinois at Chicago.
Genitourinary Oncology
Alikhaki.jpg
Ali Raza Khaki, MD
Seattle, WA
Dr. Khaki is a hematology/oncology fellow at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle, Washington.
Gynecologic Oncology
Dewdney.jpg
Summer B. Dewdney, MD
Chicago, IL
Dr. Dewdney is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at Rush Copley Medical Center. She is an assistant professor at Rush University.
Head & Neck Cancer
Michaelgibson.jpg
Michael Gibson, MD, PhD
Nashville, TN

Social-twitter-icon.png mgibson21212
LinkedIn
Dr. Gibson is board certified in Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.
Neuro-Oncology
SeemaNagpal.jpg
Seema Nagpal, MD
Palo Alto, CA
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a clinical associate professor at Stanford University
Sarcoma
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Nashville, TN

Social-twitter-icon.png ejdavis25
Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center. She is an assistant professor at Vanderbilt University.
Thoracic Oncology
TravisOsterman.jpg
Travis Osterman, DO, MS, FAMIA
Nashville, TN

Social-twitter-icon.png TravisOsterman
LinkedIn
Dr. Osterman is board certified in Medical Oncology and Clinical Informatics; he practices at Vanderbilt University Medical Center. He is an assistant professor at Vanderbilt University.
Acute Leukemias
MartinSchoen.jpg
Martin W. Schoen, MD, MPH
Saint Louis University
St. Louis, MO
Dr. Schoen is board certified in Internal Medicine and board eligible in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at Saint Louis University.
Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Sanjay mohan.png
Sanjay R. Mohan, MD, MSCI
Nashville, TN
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Aggressive Lymphomas & Lymphoproliferative disorders
TarsheenSethi.jpg
Tarsheen Sethi, MD, MSCI
Yale University
New Haven, CT

Social-twitter-icon.png tarsheen2
Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at Yale University.
Indolent Lymphomas
Sanjaisharma.jpg
Sanjai Sharma, MD
Visalia, CA
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center.
Plasma Cell Dyscrasias
Headshot Cowan.jpg
Andrew J. Cowan, MD
Seattle, WA

Social-twitter-icon.png andrewcowanmd
LinkedIn
Dr. Cowan is board certified in Hematology and Medical Oncology; he practices at the Seattle Cancer Care Alliance. He is an assistant professor at the University of Washington.
T-cell and NK-cell neoplasms
Bdholaria.jpg
Bhagirathbhai Dholaria, MBBS
Nashville, TN
Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Histiocyte Disorders
GauravGoyal.jpg
Gaurav Goyal, MD
UAB
Birmingham, AL

Social-twitter-icon.png GauravGoyalMD
Dr. Goyal is board certified in Hematology and Medical Oncology; he practices at UAB Medicine. He is an assistant professor at UAB (The University of Alabama at Birmingham).
Immuno-Oncology
Mooradian.jpg
Meghan J. Mooradian, MD
Boston, MA

LinkedIn
Dr. Mooradian is board certified in Medical Oncology; she practices at Massachusetts General Hospital. She is an instructor at Harvard Medical School.
Pediatric Oncology
Liang.jpg
Wayne H. Liang, MD, MS, FAMIA
Birmingham, AL

Social-twitter-icon.png WayneLiangMD
LinkedIn
Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children's of Alabama. He is an assistant professor at UAB.
Transplant
Hilal.jpg
Talal Hilal, MD
University of Mississippi
Jackson, MS

Social-twitter-icon.png THilalMD
Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at University of Mississippi Medical Center. He is an assistant professor at the University of Mississippi.
Classical Hematology
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Nashville, TN
Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.

Page Editors

  • Matthew Rioth, MD, MS (University of Colorado, Aurora, CO)

COI Disclosures

Please see our conflict of interest page for more details.

Name Research funding Other (honoraria, travel support, significant ownership interests, etc.) Date of disclosure
Bhagirathbhai Dholaria Takeda, Janssen, Poseida, Angiocrine Nothing to disclose Oct. 11, 2020
Gaurav Goyal Nothing to disclose Nothing to disclose Oct. 11, 2020
Laura Graham Nothing to disclose Nothing to disclose Oct. 11, 2020
Talal Hilal Nothing to disclose Nothing to disclose Oct. 12, 2020
Ali R. Khaki NIH Travel: BCAN; ASCO Oct. 12, 2020
Wayne H. Liang Nothing to disclose Nothing to disclose Oct. 12, 2020
Eric Marks Nothing to disclose Nothing to disclose Oct. 12, 2020
Meghan J. Mooradian Nothing to disclose Consultant and/or received honorarium from AstraZeneca, Nektar Pharmaceuticals, Immunai Oct. 15, 2020
Ryan Nguyen Nothing to disclose Nothing to disclose Oct. 14, 2020
Samuel R. Rubinstein Nothing to disclose Nothing to disclose Oct. 11, 2020
Candice Schwartz Nothing to disclose Nothing to disclose Oct. 12, 2020
Benjamin F. Tillman Nothing to disclose Nothing to disclose Oct. 11, 2020
Jeremy L. Warner AACR; NIH; Vanderbilt University Travel: AACR; ASCO
Ownership: HemOnc.org
Consulting: Westat, IBM Watson Health
Oct. 11, 2020
Risa L. Wong ASCO; Fred Hutchinson Cancer Research Center Nothing to disclose Oct. 11, 2020
Peter C. Yang Nothing to disclose Ownership: HemOnc.org
Stock: Merck, Pfizer
Oct. 12, 2020